Caring for patients with allergic rhinitis
| Autor: | Catherine R. Womack, Mary Lou Hayden |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
medicine.medical_specialty Rhinitis Allergic Perennial medicine.medical_treatment MEDLINE Nasal congestion Internal medicine Anti-Allergic Agents medicine Humans Pharmacologic therapy Child Glucocorticoids Administration Intranasal General Nursing Leukotriene Antagonists business.industry Rhinitis Allergic Seasonal Immunotherapy Allergen avoidance Leukotriene Receptor Antagonists Anesthesia Practice Guidelines as Topic Histamine H1 Antagonists Nasal administration medicine.symptom business |
| Zdroj: | Journal of the American Academy of Nurse Practitioners. 19:290-298 |
| ISSN: | 1745-7599 1041-2972 |
| Popis: | Purpose: Allergic rhinitis (AR) affects up to 40 million Americans, with an estimated cost of $2.7 billion per annum. This review discusses several therapeutic options that reduce the symptoms of AR, including allergen avoidance, antihistamines, intranasal corticosteroids (INS), leukotriene receptor antagonists, and immunotherapy. Data sources: The articles included in this review were retrieved by a search of Medline literature on the subjects of AR, antihistamines, INS, leukotriene antagonists, and immunotherapy, as well as current published guidelines for the treatment of AR. Conclusions: Allergen avoidance is recommended for all patients prior to pharmacologic therapy. Oral and nasal H1-antihistamines are recommended to alleviate the mild and intermittent symptoms of AR, and INS are recommended as the first-line treatment choice for mild persistent and more moderate-to-severe persistent AR. Implications for practice: There are a number of different types of therapy for the management of AR; with so many options available, successful tailoring of treatment to suit individual requirements is realistically achievable. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text